Diamonds and Dogs

6/13/22

Day One Biopharmaceuticals (DAWN) jumps 100% on positive data for brain cancer. The company tested its drug in patients age 6 months to 25 years old with an aggressive form of pediatric brain cancer. Overall, the drug achieved a 91% clinical benefit rate, meaning more than nine in 10 patients completely or partially responded, or were considered stable for six months. 64% of the patients saw tumors shrink.

Cryptocurrency takes a hit. Bitcoin fell 14% while Ethereum has dropped 16% as a small rival lending platform, Celsius Network announced that it was pausing all withdrawals and transfers between accounts in order to "honor, over time, withdrawal obligations.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.